SE9302333D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9302333D0
SE9302333D0 SE19939302333A SE9302333A SE9302333D0 SE 9302333 D0 SE9302333 D0 SE 9302333D0 SE 19939302333 A SE19939302333 A SE 19939302333A SE 9302333 A SE9302333 A SE 9302333A SE 9302333 D0 SE9302333 D0 SE 9302333D0
Authority
SE
Sweden
Prior art keywords
pct
date jan
sec
new compounds
pub
Prior art date
Application number
SE19939302333A
Other languages
English (en)
Swedish (sv)
Inventor
Robin *Boar Bernard
John *Cross Alan
Alastair *Gray Duncan
Richard *Green Alfred
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Priority to SE19939302333A priority Critical patent/SE9302333D0/xx
Publication of SE9302333D0 publication Critical patent/SE9302333D0/xx
Priority to IS4183A priority patent/IS1742B/is
Priority to JP7503999A priority patent/JPH08512313A/ja
Priority to US08/379,467 priority patent/US5747515A/en
Priority to RU96102574A priority patent/RU2137763C1/ru
Priority to BR9406924A priority patent/BR9406924A/pt
Priority to CA002164876A priority patent/CA2164876A1/en
Priority to EP94921148A priority patent/EP0707573A1/en
Priority to NZ268690A priority patent/NZ268690A/en
Priority to CN94192705A priority patent/CN1044705C/zh
Priority to SK1599-95A priority patent/SK281025B6/sk
Priority to PL94312427A priority patent/PL179021B1/pl
Priority to PCT/SE1994/000664 priority patent/WO1995001967A1/en
Priority to HU9503742A priority patent/HUT74673A/hu
Priority to AU71978/94A priority patent/AU691191B2/en
Priority to CZ9641A priority patent/CZ4196A3/cs
Priority to NO960029A priority patent/NO305862B1/no
Priority to FI960077A priority patent/FI960077A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE19939302333A 1993-07-06 1993-07-06 New compounds SE9302333D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE19939302333A SE9302333D0 (sv) 1993-07-06 1993-07-06 New compounds
IS4183A IS1742B (is) 1993-07-06 1994-06-23 Hliðstæð aðferð við að framleiða nýjar (1-fenýl-1-heterósýklýl)alkanafleiður og notkun þeirra við að vernda taugar
CZ9641A CZ4196A3 (en) 1993-07-06 1994-07-05 Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective preparations
NZ268690A NZ268690A (en) 1993-07-06 1994-07-05 Thiazole, oxazole and imidazole derivatives and medicaments
CN94192705A CN1044705C (zh) 1993-07-06 1994-07-05 (1-苯基-1-杂环基)烷烃衍生物、它们的制备方法及其用途
RU96102574A RU2137763C1 (ru) 1993-07-06 1994-07-05 Производные (1-фенил-1-гетероциклил)алкана, способ их получения, фармацевтический препарат, обладающий нейрозащитным действием при ишемии головного мозга, способ лечения гипоксических и асфиксических поражений мозга
BR9406924A BR9406924A (pt) 1993-07-06 1994-07-05 Composto processo para preparar o mesmo formulaçao farmaceutica e uso de um composto
CA002164876A CA2164876A1 (en) 1993-07-06 1994-07-05 Novel (1-phenyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents
EP94921148A EP0707573A1 (en) 1993-07-06 1994-07-05 Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
JP7503999A JPH08512313A (ja) 1993-07-06 1994-07-05 新規な（１−フェニル−１−ヘテロサイクリル）アルカン誘導体および神経保護剤としてのその使用
US08/379,467 US5747515A (en) 1993-07-06 1994-07-05 Heterocyclic compounds and compositions having nevropharmacological potential
SK1599-95A SK281025B6 (sk) 1993-07-06 1994-07-05 (1-fenyl-1-heterocyklyl)alkánové deriváty, spôsoby ich prípravy, medziprodukty na ich prípravu, farmaceutické prostriedky s ich obsahom a ich použitie
PL94312427A PL179021B1 (pl) 1993-07-06 1994-07-05 Nowa pochodna (1-fenylo-1-heterocyklo)alkanu,sposób wytwarzania nowej pochodnej (1-fenylo-1-heterocyklo)alkanui kompozycja farmaceutyczna PL PL PL PL PL
PCT/SE1994/000664 WO1995001967A1 (en) 1993-07-06 1994-07-05 Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
HU9503742A HUT74673A (en) 1993-07-06 1994-07-05 Novel (1-phenyl-1-heterocyclyl) alkane derivatives, process for producing them, pharmaceutical compositions containing them and their use as neuroprotective agents
AU71978/94A AU691191B2 (en) 1993-07-06 1994-07-05 Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
NO960029A NO305862B1 (no) 1993-07-06 1996-01-04 Nye (1-fenyl-1-heterocyklyl)alkanderivater, farmas°ytisk preparat og anvendelse av derivatene til fremstilling av neurobeskyttende midler
FI960077A FI960077A (fi) 1993-07-06 1996-01-08 Uudet (1-fenyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302333A SE9302333D0 (sv) 1993-07-06 1993-07-06 New compounds

Publications (1)

Publication Number Publication Date
SE9302333D0 true SE9302333D0 (sv) 1993-07-06

Family

ID=20390540

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939302333A SE9302333D0 (sv) 1993-07-06 1993-07-06 New compounds

Country Status (18)

Country Link
US (1) US5747515A (pt)
EP (1) EP0707573A1 (pt)
JP (1) JPH08512313A (pt)
CN (1) CN1044705C (pt)
AU (1) AU691191B2 (pt)
BR (1) BR9406924A (pt)
CA (1) CA2164876A1 (pt)
CZ (1) CZ4196A3 (pt)
FI (1) FI960077A (pt)
HU (1) HUT74673A (pt)
IS (1) IS1742B (pt)
NO (1) NO305862B1 (pt)
NZ (1) NZ268690A (pt)
PL (1) PL179021B1 (pt)
RU (1) RU2137763C1 (pt)
SE (1) SE9302333D0 (pt)
SK (1) SK281025B6 (pt)
WO (1) WO1995001967A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774596B1 (fr) * 1998-02-11 2000-03-17 Rhone Poulenc Rorer Sa Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer
ATE293102T1 (de) * 1998-04-23 2005-04-15 Takeda Pharmaceutical Naphthalene derivate ,ihre herstellung und verwendung
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
US6156775A (en) * 1999-03-01 2000-12-05 Novartis Ag Use of fluorinated triazoles in treating affective and attention disorders
CA2375287A1 (en) * 1999-06-22 2000-12-28 Takeda Chemical Industries, Ltd. Production method of imidazole derivatives
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
WO2008064317A1 (en) * 2006-11-22 2008-05-29 University Of Medicine And Dentistry Of New Jersey Lipophilic opioid receptor active compounds
WO2013033004A2 (en) * 2011-08-30 2013-03-07 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
CN104932538B (zh) * 2015-07-03 2018-02-23 中国计量科学研究院 光机旋转装置

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE121520C (pt) *
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4649146A (en) * 1983-01-31 1987-03-10 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives and pharmaceutical composition comprising the same
FR2625199B1 (fr) * 1987-12-23 1991-03-22 Irceba Derives oxyimino du thiazole, procede de preparation et utilisation en therapeutique
JPH01249760A (ja) * 1988-03-29 1989-10-05 Yamaha Corp ホトクロミック化合物
JPH0291076A (ja) * 1988-09-28 1990-03-30 Tokuyama Soda Co Ltd フォトクロミック性化合物及びその製造方法
TW224461B (pt) * 1990-09-18 1994-06-01 Ciba Geigy Ag
JPH06505239A (ja) * 1991-01-31 1994-06-16 ワーナー−ランバート・コンパニー 抗炎症剤として有用な４，６−ジ−第三ブチル−５−ヒドロキシ−１，３−ピリミジンの置換されたヘテロアリール類似体
US5177079A (en) * 1991-01-31 1993-01-05 Warner-Lambert Company 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
GB9125924D0 (en) * 1991-06-18 1992-02-05 Orion Yhtymae Oy Stereoisomers of an imidazole derivative

Also Published As

Publication number Publication date
IS4183A (is) 1995-01-07
SK281025B6 (sk) 2000-11-07
NO960029L (no) 1996-01-04
HU9503742D0 (en) 1996-02-28
EP0707573A1 (en) 1996-04-24
CN1044705C (zh) 1999-08-18
JPH08512313A (ja) 1996-12-24
BR9406924A (pt) 1996-07-30
FI960077A0 (fi) 1996-01-08
CA2164876A1 (en) 1995-01-19
AU7197894A (en) 1995-02-06
WO1995001967A1 (en) 1995-01-19
AU691191B2 (en) 1998-05-14
CZ4196A3 (en) 1996-06-12
NZ268690A (en) 1997-11-24
NO305862B1 (no) 1999-08-09
SK159995A3 (en) 1996-06-05
NO960029D0 (no) 1996-01-04
PL312427A1 (en) 1996-04-29
US5747515A (en) 1998-05-05
FI960077A (fi) 1996-01-08
PL179021B1 (pl) 2000-07-31
HUT74673A (en) 1997-01-28
RU2137763C1 (ru) 1999-09-20
CN1126990A (zh) 1996-07-17
IS1742B (is) 2000-02-21

Similar Documents

Publication Publication Date Title
TNSN97087A1 (fr) 4(3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
EA200000488A1 (ru) Замена катехина на биоизостеру индазола в терапевтически активных соединениях
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
RU94045846A (ru) Применение производных бензотиофена для ингибирования тромбина
PT958296E (pt) Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
LU91254I2 (fr) Daptomycine et ses dérivés pharmaceutiquement acceptables (cubicinr)
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
NO306677B1 (no) Heterosykliske forbindelser, farmasöytiske preparater og anvendelse av en slik forbindelse til fremstilling av et medikament
BR9507073A (pt) Composto processos para preparar o mesmo e para tratar uma doença no sistema nervoso central composiçao farmacêutica e uso do composto
ES2141957T3 (es) Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
TNSN97044A1 (fr) Derives de quinoxalinedone, procedes et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant.
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
BE899564A (fr) Composition pharmaceutique pour l'administration parenterale a base de nimodipin et procede pour sa preparation.
PT1514542E (pt) Composição medicamentosa incluindo tacrina ou donepezilo para melhorar as funções cerebrais
DK0738269T5 (da) Piperidinderivater med PAF-antagonistaktivitet
SE9302333D0 (sv) New compounds
ATE219044T1 (de) Fluorosubstituierte adamantan-derivate
ATE269865T1 (de) Pyrazolo(3,4-g)chinoxaline als pdgf-rezeptor protein tyrosin-kinase inhibitoren
PT1039900E (pt) Agentes terapeuticos
DE69315699D1 (de) Inhibitoren gegen die aggregation von blutplättchen
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
NO923413D0 (no) Terapeutiske benzazepin-forbindelser
DE69030665D1 (de) (1,2n) und (3,2n)-karbozyklische-2-amino-tetralinderivate
US3812257A (en) Uricosuric agent
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders